MedPath

HAEMOVENIN

HAEMOVENIN

Discontinued
DIN Number

00226254

Drug Class

Human

Market Date

Dec 31, 1972

Company
HC

dr reckeweg and co

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00226254
AIG Number0903715001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (9)

AESCULUS HIPPOCASTANUMActive
Strength: 30 X / X
Monograph: AESCULUS HIPPOCASTANUM
BELLADONNAActive
Strength: 12 X / X
Monograph: BELLADONNA
CALCIUM FLUORIDEActive
Strength: 12 X / X
Monograph: CALCIUM FLUORIDE
ERGOTActive
Strength: 30 X / X
Monograph: ERGOT
HAMAMELIS VIRGINIANAActive
Strength: 6 X / X
Monograph: HAMAMELIS VIRGINIANA
LACHESISActive
Strength: 12 X / X
Monograph: LACHESIS
MEZEREUMActive
Strength: 8 X / X
Monograph: MEZEREUM
MILK THISTLEActive
Strength: 12 X / X
Monograph: MILK THISTLE
PULSATILLAActive
Strength: 30 X / X
Monograph: PULSATILLA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.